Fifteen Cases of Endoscopic Treatment of Acute Subdural Hematoma with Small Craniotomy under Local Anesthesia: Endoscopic Hematoma Removal Reduces the Intraoperative Bleeding Amount and the Operative Time Compared with Craniotomy in Patients Aged 70 or Older.


Journal

Neurologia medico-chirurgica
ISSN: 1349-8029
Titre abrégé: Neurol Med Chir (Tokyo)
Pays: Japan
ID NLM: 0400775

Informations de publication

Date de publication:
15 Sep 2020
Historique:
pubmed: 18 8 2020
medline: 17 8 2021
entrez: 18 8 2020
Statut: ppublish

Résumé

We report cases of acute subdural hematoma (ASDH) treated by endoscopic hematoma removal with a small craniotomy under local anesthesia. From 2015 to 2019, we retrospectively analyzed 15 ASDH patients who were 70 years or older and met our criteria for endoscopic treatment: (1) comorbidities indicated risks associated with a large craniotomy under general anesthesia; (2) decompressive craniectomy was unlikely; and (3) an enlarging hematoma was absent. We also performed a case-control study using the inverse probability weighting method to compare the 15 patients to 20 ASDH patients who were 70 years or older, met criteria (2) and (3), and were treated by craniotomy between 2012 and 2019. Among the 15 ASDH patients, the median age was 86 (range, 70-101) years, and fall was the common cause. The median Glasgow Coma Scale score on admission, operative time, stay time in the operation room, and bleeding amount were 8 (6-15), 91 (48-156) min, 120 (80-205) min, and 20 (5-400) mL, respectively. The extraction rates of all the hematomas exceeded 90%. No patients required conversion to craniotomy under general anesthesia. Three patients had favorable outcomes, and five died. The comparison with craniotomy revealed that the endoscopic procedure reduced the intraoperative bleeding amount, operative time, and stay time in the operation room (p <0.001, p = 0.02, and p <0.001, respectively). In summary, endoscopic hematoma removal for selected ASDH patients aged 70 years or older did not improve functional outcomes but reduced the bleeding amount and the operative time compared with craniotomy.

Identifiants

pubmed: 32801274
doi: 10.2176/nmc.oa.2020-0071
pmc: PMC7490600
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

439-449

Références

J Neurotrauma. 2019 Feb 15;36(4):517-522
pubmed: 29943683
J Neurol Surg A Cent Eur Neurosurg. 2020 Jan;81(1):10-16
pubmed: 31272119
No Shinkei Geka. 2019 Jul;47(7):753-760
pubmed: 31358694
J Stroke Cerebrovasc Dis. 2011 May-Jun;20(3):208-13
pubmed: 20621516
No Shinkei Geka. 2016 Jun;44(6):455-62
pubmed: 27270143
Stroke. 1998 Sep;29(9):1799-801
pubmed: 9731597
World Neurosurg. 2019 Jun;126:e1235-e1241
pubmed: 30885866
Brain Res. 2002 Aug 23;947(1):131-9
pubmed: 12144861
J Neurotrauma. 2008 Feb;25(2):79-93
pubmed: 18260791
Crit Care. 2012 Jul 26;16(4):228
pubmed: 22839302
Neurosurgery. 2017 Jan 01;80(1):6-15
pubmed: 27654000
J Neurosurg. 1991 Feb;74(2):212-8
pubmed: 1988590
J Neurosurg. 2019 Apr 12;:1-7
pubmed: 30978691
Neurosurg Rev. 2016 Apr;39(2):237-40; discussion 240
pubmed: 26382645
Br J Neurosurg. 2011 Jun;25(3):363-8
pubmed: 21355766
Lancet Neurol. 2011 Feb;10(2):131-9
pubmed: 21169065
Case Rep Neurol Med. 2016;2016:2056190
pubmed: 26981295
Neurosurgery. 2002 Mar;50(3):503-8; discussion 508-9
pubmed: 11841717
J Neurosurg Anesthesiol. 2013 Apr;25(2):98-134
pubmed: 23434749
J Trauma Acute Care Surg. 2012 May;72(5):1135-9
pubmed: 22673237
J Clin Neurosci. 2013 Dec;20(12):1751-3
pubmed: 23962631
World Neurosurg. 2014 Dec;82(6):1300-6
pubmed: 25128777
Crit Care. 2017 Aug 23;21(1):222
pubmed: 28830477
J Clin Neurosci. 2019 Mar;61:311-314
pubmed: 30472341
J Neurosurg. 2015 Oct;123(4):1065-9
pubmed: 25909568
J Neuroinflammation. 2010 Mar 11;7:19
pubmed: 20222971
World Neurosurg. 2016 Oct;94:493-500
pubmed: 27465419
Case Rep Neurol. 2014 Jan 18;5(3):208-13
pubmed: 24659965
Acute Med Surg. 2017 Jul 17;4(4):451-453
pubmed: 29123907
Neurol Med Chir (Tokyo). 2014;54(11):887-94
pubmed: 25367584
Acta Neurochir (Wien). 2018 Feb;160(2):241-248
pubmed: 29192373

Auteurs

Masahito Katsuki (M)

Department of Neurosurgery, Suwa Red Cross Hospital.

Yukinari Kakizawa (Y)

Department of Neurosurgery, Suwa Red Cross Hospital.

Akihiro Nishikawa (A)

Department of Neurosurgery, Suwa Red Cross Hospital.

Keiko Kunitoki (K)

Harvard School of Public Health.

Yasunaga Yamamoto (Y)

Department of Neurosurgery, Suwa Red Cross Hospital.

Naomichi Wada (N)

Department of Neurosurgery, Suwa Red Cross Hospital.

Toshiya Uchiyama (T)

Department of Neurosurgery, Suwa Red Cross Hospital.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH